You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 8,273,721


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,273,721
Title:Combination treatment for bladder cancer
Abstract: Novel methods useful for treating a patient with bladder cancer such as superficial bladder cancer includes administering to the patient a therapeutically effective amount of valrubicin and trospium chloride.
Inventor(s): Shipley; James E. (Lexington, MA)
Assignee: Endo Pharmaceuticals Solutions Inc. (Chadds Ford, PA)
Application Number:12/397,831
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Patent Landscape: A Comprehensive Analysis of US Patent 8,273,721

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with exclusive rights to their inventions. However, the patent landscape is complex and ever-evolving, influenced by various factors including legal reforms, technological advancements, and economic trends. This article delves into a comprehensive analysis of the claims and the broader patent landscape, using US Patent 8,273,721 as a case study.

The Patent System in the United States

The U.S. Patent and Trademark Office (USPTO) is responsible for reviewing and granting patents. Despite its importance, the USPTO has faced criticism for its alleged leniency in granting patents, which some argue has led to the issuance of frivolous or low-quality patents[1].

Patent Approval Rates

Studies have shown that the approval rate for patent applications has decreased over time, particularly in fields like "Drugs and Medical Instruments" and "Computers and Communications." Only about 55.8% of patent applications filed between 1996 and 2013 were granted without using continuation procedures[1].

The Role of the Patent Trial and Appeal Board (PTAB)

The Leahy-Smith America Invents Act (AIA) of 2011 introduced significant changes to the U.S. patent system, including the creation of the PTAB. This board allows for administrative challenges to the validity of patents through inter partes review (IPR) and post-grant review (PGR). These processes are faster and less expensive than judicial proceedings and require a lower burden of proof to invalidate patents[2].

US Patent 8,273,721: An Overview

To conduct a comprehensive analysis, let's consider a hypothetical example using US Patent 8,273,721, though the specific details of this patent are not provided here.

Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention. Effective claims must be novel, non-obvious, and useful. The analysis of claims involves understanding the language and scope of each claim, as well as identifying any potential vulnerabilities or areas for improvement.

Prior Art Search

A crucial step in patent analysis is the prior art search, which determines whether an invention is novel and non-obvious. This involves identifying relevant prior art that could impact the patent's validity or enforceability[3].

Patent Analysis Techniques

Technology Landscape Analysis

Patent analysis helps in understanding the current state of technology within a specific industry. It reveals trends in innovation, emerging technologies, and areas of rapid development. For example, the Artificial Intelligence Patent Dataset (AIPD) by the USPTO identifies patents related to AI, providing insights into the evolution of AI technology[5].

Competitive Intelligence

Analyzing patents provides insights into the intellectual property strategies of competitors. It helps in understanding what technologies and innovations rival companies are investing in and potentially planning to commercialize[3].

Innovation Trends

Patent data can be used to identify long-term innovation trends and areas of interest for companies and researchers. This information can inform research and development (R&D) strategies and investment decisions[3].

Citation Analysis

Examining patent citations helps in understanding how a patent relates to prior and subsequent innovations. This type of analysis can gauge the importance of a patent within a technological field[3].

Geographical Distribution of Patent Activity

The geographical distribution of patent activity can provide valuable insights. For instance, patent intensity, defined as the number of patents issued to inventors residing in a county divided by the total population, can highlight regions of high innovation activity[4].

Legal and Regulatory Framework

The Leahy-Smith America Invents Act (AIA)

The AIA introduced significant reforms, including the shift from a "first-to-invent" to a "first-to-file" system. It also created new administrative procedures like IPR and PGR, which have been instrumental in challenging the validity of patents[2].

Patent Subject Matter Eligibility

The USPTO has issued guidelines for determining whether a patent application seeks to claim ineligible subject matter, such as laws of nature, natural phenomena, or abstract ideas. The Alice/Mayo test is used to determine if a patent claim has an "inventive concept" that transforms the nature of the ineligible concept[2].

Criticisms and Challenges

Patent Trolls

One of the criticisms of the patent system is the issue of "patent trolls," entities that obtain patents with dubious claims solely to extract rents from genuine inventors. The PTAB was partly created to address this issue by weeding out poor-quality patents[2].

Uncertainty in Patent Rights

Critics argue that the PTAB has made it too easy to challenge patents, creating uncertainty in patent rights and potentially stifling innovation. This uncertainty can discourage investments in patent-intensive industries and early-stage companies[2].

Strategic Insights from Patent Analysis

Identifying White Spaces

Patent analysis can help identify areas where there is a lack of innovation or patent activity, known as "white spaces." These areas can be lucrative for companies looking to innovate and secure new patents[3].

Assessing the Competitive Landscape

By analyzing the patent portfolios of competitors, companies can assess their strengths and weaknesses. This information can inform business strategies and R&D investments[3].

Patent Valuation

Evaluating the potential economic value of patents involves considering factors such as market size, potential licensing opportunities, and litigation risks. This helps in making informed decisions about patent acquisition or enforcement[3].

Key Takeaways

  • Patent Approval Rates: The approval rate for patent applications has decreased over time, especially in certain technology fields.
  • PTAB and Administrative Challenges: The PTAB provides a faster and less expensive way to challenge patent validity compared to judicial proceedings.
  • Patent Analysis Techniques: Various techniques such as technology landscape analysis, competitive intelligence, and citation analysis are crucial for understanding the patent landscape.
  • Geographical Distribution: Patent activity varies geographically, with some regions showing higher innovation intensity.
  • Legal and Regulatory Framework: The AIA and guidelines on patent subject matter eligibility are key components of the U.S. patent system.
  • Criticisms and Challenges: Issues such as patent trolls and uncertainty in patent rights continue to affect the patent landscape.

FAQs

What is the current patent approval rate in the United States?

The patent approval rate has decreased over time, with approximately 55.8% of applications being granted without using continuation procedures between 1996 and 2013[1].

How does the PTAB impact patent validity challenges?

The PTAB allows for administrative challenges to patent validity through IPR and PGR, which are faster and less expensive than judicial proceedings and require a lower burden of proof to invalidate patents[2].

What is the importance of prior art search in patent analysis?

Prior art search is essential to determine whether an invention is novel and non-obvious, which is crucial for the success of the patent application[3].

How can patent analysis help in identifying innovation trends?

Patent data can be used to identify long-term innovation trends and areas of interest for companies and researchers, informing R&D strategies and investment decisions[3].

What are the criticisms of the PTAB?

Critics argue that the PTAB has made it too easy to challenge patents, creating uncertainty in patent rights and potentially stifling innovation[2].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Congressional Research Service. (2024). The Patent Trial and Appeal Board and Inter Partes Review. Congressional Research Service Report R48016.
  3. Evalueserve. Patent Analysis.
  4. National Center for Science and Engineering Statistics. (2024). Invention, Knowledge Transfer, and Innovation.
  5. United States Patent and Trademark Office. (2023). Artificial Intelligence Patent Dataset (AIPD 2023).

More… ↓

⤷  Subscribe

Details for Patent 8,273,721

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 May 05, 2004 8,273,721 2028-03-05
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 December 02, 2004 8,273,721 2028-03-05
Amphastar Pharmaceuticals, Inc. AMPHADASE hyaluronidase Injection 021665 October 26, 2004 8,273,721 2028-03-05
Akorn, Inc. HYDASE hyaluronidase Injection 021716 October 25, 2005 8,273,721 2028-03-05
Halozyme Therapeutics, Inc. HYLENEX RECOMBINANT hyaluronidase human Injection 021859 December 02, 2005 8,273,721 2028-03-05
Genentech, Inc. RITUXAN HYCELA rituximab and hyaluronidase human Injection 761064 June 22, 2017 8,273,721 2028-03-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.